Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Patient Risk Stratification Market Expected to Grow Between 2025 And 2029?
The market size of patient risk stratification has witnessed a substantial increase in recent times, expanding from $2.15 billion in 2024 to a projected $2.81 billion in 2025. This leads to a compound annual growth rate (CAGR) of 30.9%. This significant increase during the historical period can be associated with several factors including enhanced digitization, heightened risk, an aging population, an increase in medical errors, and wider use of electronic health records (EHR).
The market size for patient risk stratification is predicted to undergo drastic expansion in the coming years. The market is projected to escalate to$8.2 billion in 2029,” recording a compound annual growth rate (CAGR) of 30.7%. The predicted growth during the forecast time can be associated with factors such as the surge in the middle-class population and health insurance, escalating incidence of chronic diseases, increasing adoptions of predictive analytics, more focus on social determinants of health (SDOH), and a broader application of technology. The emerging trends during this projection period include advancements in data analytics, the role of artificial intelligence (AI), progress in machine learning, technological upgrades, the introduction of groundbreaking tools, ongoing technological development in healthcare, advancements in wearable technology, and remote patient monitoring.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp
Which Primay Drivers Are Accelerating Growth in the Patient Risk Stratification Market?
Anticipations are that the escalating issue of chronic illnesses will boost the patient risk stratification market’s expansion. Chronic ailments are long-term health issues that typically last for three months or more. Factors such as the aging population, unhealthy lifestyle habits, urbanization, environmental influences, limited access to healthcare, economic variation, and increased stress can all contribute to the rising occurrence of these diseases. Patient risk stratification techniques allow for the identification of individuals at various risk levels for chronic diseases, promoting personalized care, early intervention, optimized resource management, and enhanced health outcomes. For example, the National Center for Biotechnology Information (NCBI), a U.S.-based National Library of Medicine, projected in January 2023 that the number of individuals aged 50 and older with at least one chronic disease would rise by 99.5%, to 142.66 million in 2050 from 71.522 million in 2020. Moreover, in September 2022, the Switzerland-based World Health Organization (WHO) 2022 Highlights stated that chronic diseases comprised 74% of all global deaths, equal to 41 million deaths annually. Cardiovascular diseases resulted in 17.9 million deaths, cancer resulted in 9.3 million, chronic respiratory diseases resulted in 4.1 million, and diabetes resulted in 2.0 million deaths. Thus, it’s the escalating crisis of chronic diseases that propels the growth of the patient risk stratification market.
Which Primary Segments of the Patient Risk Stratification Market Are Driving Growth and Industry Transformations?
The patient risk stratificationmarket covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model
2) By Component: Software; Services
3) By Delivery Model: On-Premise; Cloud-Based
4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications
5) By End User: Healthcare Providers; Healthcare Payers; Other End Users
Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Patient Risk Stratification Market?# Market?
North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Patient Risk Stratification Industry Dynamics?
Prominent firms in the patient risk stratification sector are concentrating on leveraging technological advancements in healthcare, like artificial intelligence (AI) in disease screening. This move is aimed at refining early detection, enhancing patient results, and curbing healthcare expenditure through facilitating more accurate risk analyses and customized treatment plans. AI in disease screening employs advanced algorithms and machine learning to examine medical data, thereby facilitating early disease diagnosis and improving the precision of diagnostics by rapidly processing large volumes of data. To illustrate, in May 2024, WELL Health Technologies Corporation, a healthcare company based in Canada, in partnership with its investee company HEALWELL AI, another Canada-based medical firm specializing in the use of AI and data science in preventive care, introduced WELL AI Decision Support (WAIDS). This initiative is targeted at rare ailments and now incorporates screening for chronic conditions like kidney disease, hypertension, and diabetes. It has the capacity to detect more than 100 diseases and provide risk stratification, thus assisting doctors to recognize care gaps and obtain actionable data when providing care.
View the full report here:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report
What Parameters Are Used to Define the Patient Risk Stratification Market?
Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model